참고문헌
- Sarkar NK, Clarke DD and Waelsch H (1957) An enzymically catalyzed incorporation of amines into proteins. Biochim Biophys Acta 25, 451-452 https://doi.org/10.1016/0006-3002(57)90512-7
- Grenard P, Bates MK and Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J Biol Chem 276, 33066-33078 https://doi.org/10.1074/jbc.M102553200
- Mehta K (2005) Mammalian transglutaminases: a family portrait. Prog Exp Tumor Res 38, 1-18
- Park D, Choi SS and Ha KS (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39, 619-631 https://doi.org/10.1007/s00726-010-0500-z
- Achyuthan KE and Greenberg CS (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262, 1901-1906
- Nakaoka H, Perez DM, Baek KJ et al (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264, 1593-1596 https://doi.org/10.1126/science.7911253
- Hasegawa G, Suwa M, Ichikawa Y et al (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373, 793-803 https://doi.org/10.1042/bj20021084
- Jones RA, Nicholas B, Mian S, Davies PJ and Griffin M (1997) Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 110, 2461-2472
- Mishra S and Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339, 726-730 https://doi.org/10.1016/j.bbrc.2005.11.071
- Mishra S and Murphy LJ (2004) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279, 23863-23868 https://doi.org/10.1074/jbc.M311919200
- Lorand L and Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4, 140-156 https://doi.org/10.1038/nrm1014
- Takeuchi Y, Ohashi H, Birckbichler PJ and Ikejima T (1998) Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity. Z Naturforsch C 53, 352-358
- Nurminskaya MV and Belkin AM (2012) Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol 294, 1-97
- Esposito C and Caputo I (2005) Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 272, 615-631 https://doi.org/10.1111/j.1742-4658.2004.04476.x
- Lesort M, Tucholski J, Miller ML and Johnson GV (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61, 439-463 https://doi.org/10.1016/S0301-0082(99)00052-0
- Dieterich W, Ehnis T, Bauer M et al (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3, 797-801 https://doi.org/10.1038/nm0797-797
- Sollid LM, Molberg O, McAdam S and Lundin KE (1997) Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut 41, 851-852 https://doi.org/10.1136/gut.41.6.851
- Birckbichler PJ, Orr GR, Conway E and Patterson MK (1977) Transglutaminase activity in normal and transformed cells. Cancer Res 37, 1340-1344
- Griffin M, Smith LL and Wynne J (1979) Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol 60, 653-661
- Gentile V, Davies PJ and Baldini A (1994) The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization. Genomics 20, 295-297 https://doi.org/10.1006/geno.1994.1170
- Fesus L and Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27, 534-539 https://doi.org/10.1016/S0968-0004(02)02182-5
- Fraij BM and Gonzales RA (1997) Organization and structure of the human tissue transglutaminase gene. Biochim Biophys Acta 1354, 65-71 https://doi.org/10.1016/S0167-4781(97)00132-2
- Kiraly R, Demeny M and Fesus L (2011) Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein. FEBS J 278, 4717-4739 https://doi.org/10.1111/j.1742-4658.2011.08345.x
- Shrestha R, Tatsukawa H, Shrestha R et al (2015) Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells. Cell Death Dis 6, e2002 https://doi.org/10.1038/cddis.2015.339
- Murthy SN, Iismaa S, Begg G, Freymann DM, Graham RM and Lorand L (2002) Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity. Proc Natl Acad Sci U S A 99, 2738-2742 https://doi.org/10.1073/pnas.052715799
- Lee KN, Arnold SA, Birckbichler PJ et al (1993) Sitedirected mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim Biophys Acta 1202, 1-6 https://doi.org/10.1016/0167-4838(93)90055-V
- Yee VC, Le Trong I, Bishop PD, Pedersen LC, Stenkamp RE and Teller DC (1996) Structure and function studies of factor XIIIa by x-ray crystallography. Semin Thromb Hemost 22, 377-384 https://doi.org/10.1055/s-2007-999035
- Pinkas DM, Strop P, Brunger AT and Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5, e327 https://doi.org/10.1371/journal.pbio.0050327
- Kuo TF, Tatsukawa H and Kojima S (2011) New insights into the functions and localization of nuclear transglutaminase 2. FEBS J 278, 4756-4767 https://doi.org/10.1111/j.1742-4658.2011.08409.x
- Milakovic T, Tucholski J, McCoy E and Johnson GV (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279, 8715-8722 https://doi.org/10.1074/jbc.M308479200
- Malorni W, Farrace MG, Matarrese P et al (2009) The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrialdependent apoptosis. Cell Death Differ 16, 1480-1492 https://doi.org/10.1038/cdd.2009.100
- Stephens P, Grenard P, Aeschlimann P et al (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117, 3389-3403 https://doi.org/10.1242/jcs.01188
- Mhaouty-Kodja S (2004) Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol Cell 96, 363-367 https://doi.org/10.1111/j.1768-322X.2004.tb01427.x
- Dupuis M, Levy A and Mhaouty-Kodja S (2004) Functional coupling of rat myometrial alpha 1-adrenergic receptors to Gh alpha/tissue transglutaminase 2 during pregnancy. J Biol Chem 279, 19257-19263 https://doi.org/10.1074/jbc.M314299200
- Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C and Sollid LM (2010) Redox regulation of transglutaminase 2 activity. J Biol Chem 285, 25402-25409 https://doi.org/10.1074/jbc.M109.097162
- DiRaimondo TR, Plugis NM, Jin X and Khosla C (2013) Selective inhibition of extracellular thioredoxin by asymmetric disulfides. J Med Chem 56, 1301-1310 https://doi.org/10.1021/jm301775s
- Shin DM, Jeon JH, Kim CW et al (2008) TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 22, 2498-2507 https://doi.org/10.1096/fj.07-095455
- Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM and Iismaa SE (2006) Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem 281, 12603-12609 https://doi.org/10.1074/jbc.M600146200
- Fabbi M, Marimpietri D, Martini S et al (1999) Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ. 6, 992-1001 https://doi.org/10.1038/sj.cdd.4400573
- Luciani A, Villella VR, Vasaturo A et al (2009) SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol 183, 2775-2784 https://doi.org/10.4049/jimmunol.0900993
- Ku BM, Kim DS, Kim KH et al (2013) Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma. FASEB J 27, 3487-3495 https://doi.org/10.1096/fj.12-224220
- Min B, Park H, Lee S et al (2016) CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer. Oncogene 35, 3718-3728 https://doi.org/10.1038/onc.2015.439
- Norlund MA, Lee JM, Zainelli GM and Muma NA (1999) Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res 851, 154-163 https://doi.org/10.1016/S0006-8993(99)02179-4
- Johnson GV, Cox TM, Lockhart JP, Zinnerman MD, Miller ML and Powers RE (1997) Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res 751, 323-329 https://doi.org/10.1016/S0006-8993(96)01431-X
- Shinagawa R, Masuda S, Sasaki R, Ikura K and Takahata K (1997) In vitro neurotoxicity of amyloid beta-peptide cross-linked by transglutaminase. Cytotechnology 23, 77-85 https://doi.org/10.1023/A:1007999114779
- Curro M, Ferlazzo N, Condello S, Caccamo D and Lentile R (2010) Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells. Amino Acids 39, 1427-1433 https://doi.org/10.1007/s00726-010-0605-4
- Hartley DM, Zhao C, Speier AC et al (2008) Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem 283, 16790-16800 https://doi.org/10.1074/jbc.M802215200
- Boros S, Kamps B, Wunderink L, de Bruijn W, de Jong WW and Boelens WC (2004) Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta. FEBS Lett 576, 57-62 https://doi.org/10.1016/j.febslet.2004.08.062
- de Jager M, van der Wildt B, Schul E et al (2013) Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy. Neurobiol Aging 34, 1159-1169 https://doi.org/10.1016/j.neurobiolaging.2012.10.005
- Zhang W, Johnson BR and Bjornsson TD (1997) Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. Life Sci 60, 2323-2332 https://doi.org/10.1016/S0024-3205(97)00288-9
- Zemaitaitis MO, Lee JM, Troncoso JC and Muma NA (2000) Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol 59, 983-989 https://doi.org/10.1093/jnen/59.11.983
- Tucholski J, Kuret J and Johnson GV (1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73, 1871-1880
- Halverson RA, Lewis J, Frausto S, Hutton M and Muma NA (2005) Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. J Neurosci 25, 1226-1233 https://doi.org/10.1523/JNEUROSCI.3263-04.2005
- Kalia LV and Lang AE (2015) Parkinson's disease. Lancet 386, 896-912 https://doi.org/10.1016/S0140-6736(14)61393-3
- Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55, 259-272 https://doi.org/10.1097/00005072-199603000-00001
- Lin MK and Farrer MJ (2014) Genetics and genomics of Parkinson's disease. Genome Med 6, 48 https://doi.org/10.1186/gm566
- Chai C and Lim KL (2013) Genetic insights into sporadic Parkinson's disease pathogenesis. Curr Genomics 14, 486-501
- Beck KE, De Girolamo LA, Griffin M and Billett EE (2006) The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells. Neurosci Lett 405, 46-51 https://doi.org/10.1016/j.neulet.2006.06.061
- Verhaar R, Jongenelen CA, Gerard M et al (2011) Blockade of enzyme activity inhibits tissue transglutaminasemediated transamidation of alpha-synuclein in a cellular model of Parkinson's disease. Neurochem Int 58, 785-793 https://doi.org/10.1016/j.neuint.2011.03.004
- Junn E, Ronchetti RD, Quezado MM, Kim SY and Mouradian MM (2003) Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 100, 2047-2052 https://doi.org/10.1073/pnas.0438021100
- Schmid AW, Chiappe D, Pignat V et al (2009) Dissecting the mechanisms of tissue transglutaminase-induced crosslinking of alpha-synuclein: implications for the pathogenesis of Parkinson disease. J Biol Chem 284, 13128-13142 https://doi.org/10.1074/jbc.M809067200
- Sato H, Arawaka S, Hara S et al (2011) Authentically phosphorylated alpha-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease. J Neurosci 31, 16884-16894 https://doi.org/10.1523/JNEUROSCI.3967-11.2011
- Min B, Kwon YC, Choe KM and Chung KC (2015) PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation. J Neurosci Res 93, 722-735 https://doi.org/10.1002/jnr.23535
- Verhaar R, Drukarch B, Bol JG, Jongenelen CA, Musters RJ and Wilhelmus MM (2012) Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease. Neurobiol Dis 45, 839-850 https://doi.org/10.1016/j.nbd.2011.10.012
- Wilhelmus MM, Verhaar R, Andringa G et al (2011) Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain. Brain Pathol 21, 130-139 https://doi.org/10.1111/j.1750-3639.2010.00429.x
- Gibrat C, Bousquet M, Saint-Pierre M et al (2010) Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor. Prog Neuropsychopharmacol Biol Psychiatry 34, 193-203 https://doi.org/10.1016/j.pnpbp.2009.11.005
- Tremblay ME, Saint-Pierre M, Bourhis E, Levesque D, Rouillard C and Cicchetti F (2006) Neuroprotective effects of cystamine in aged parkinsonian mice. Neurobiol Aging 27, 862-870 https://doi.org/10.1016/j.neurobiolaging.2005.04.004
- Davies SW, Turmaine M, Cozens BA et al (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548 https://doi.org/10.1016/S0092-8674(00)80513-9
- Zainelli GM, Ross CA, Troncoso JC, Fitzgerald JK and Mumna NA (2004) Calmodulin regulates transglutaminase 2 cross-linking of huntingtin. J Neurosci 24, 1954-1961 https://doi.org/10.1523/JNEUROSCI.4424-03.2004
- Mastroberardino PG, Iannicola C, Nardacci R et al (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9, 873-880 https://doi.org/10.1038/sj.cdd.4401093
- Bailey CD and Johnson GV (2005) Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregateindependent mechanisms. J Neurochem 92, 83-92 https://doi.org/10.1111/j.1471-4159.2004.02839.x
- Sun L, Xu S, Zhou M, Wang C, Wu Y and Chan P (2010) Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice. Brain Res 1335, 74-82 https://doi.org/10.1016/j.brainres.2010.03.079
- Sung K, Kamiya N, Kawata N, Kamiya S and Goto M (2010) Functional glass surface displaying a glutamyl donor substrate for transglutaminase-mediated protein immobilization. Biotechnol J 5, 456-462 https://doi.org/10.1002/biot.200900302
- Karpuj MV, Becher MW, Springer JE et al (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8, 143-149 https://doi.org/10.1038/nm0202-143
- Dedeoglu A, Kubilus JK, Jeitner TM et al (2002) Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci 22, 8942-8950 https://doi.org/10.1523/JNEUROSCI.22-20-08942.2002
- Wang X, Sarkar A, Cicchetti F et al (2005) Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. J Neurol Sci 231, 57-66 https://doi.org/10.1016/j.jns.2004.12.011
- Case A, Ni J, Yeh LA and Stein RL (2005) Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors. Anal Biochem 338, 237-244 https://doi.org/10.1016/j.ab.2004.09.047
피인용 문헌
- Concurrent detection of lysosome and tissue transglutaminase activation in relation to cell cycle position during apoptosis induced by different anticancer drugs pp.15524922, 2018, https://doi.org/10.1002/cyto.a.23652
- Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects vol.475, pp.9, 2018, https://doi.org/10.1042/BCJ20170601
- vol.294, pp.2, 2018, https://doi.org/10.1074/jbc.RA118.005489
- The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression vol.7, pp.2, 2019, https://doi.org/10.3390/medsci7020019